SP259EFFECTS OF EMPAGLIFLOZIN ON RENAL OUTCOMES ACROSS KDIGO RISK CATEGORIES: RESULTS FROM THE EMPA-REG OUTCOME® TRIAL
暂无分享,去创建一个
A. Levin | C. Wanner | V. Perkovic | D. Wheeler | M. Mattheus | M. Eynatten | A. Koitka‐Weber | A. Levin
暂无分享,去创建一个
A. Levin | C. Wanner | V. Perkovic | D. Wheeler | M. Mattheus | M. Eynatten | A. Koitka‐Weber | A. Levin